financetom
Business
financetom
/
Business
/
Airbus deliveries rose 2% in first half, sources say
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Airbus deliveries rose 2% in first half, sources say
Jul 1, 2024 2:00 PM

PARIS (Reuters) - Airbus delivered a preliminary total of around 67 airplanes in June, bringing the total for the first half of the year to around 323 aircraft, up 2% from the same period last year, industry sources said on Monday.

Airbus, which last week cut its delivery forecast for the full year to 770 planes from 800 amid supply chain concerns, declined to comment ahead of the release of monthly and half-yearly data expected on July 8.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Affiliated Managers Group Appoints COO, CFO
Affiliated Managers Group Appoints COO, CFO
Mar 25, 2024
11:55 AM EDT, 03/25/2024 (MT Newswires) -- Affiliated Managers Group ( AMG ) said Monday that Thomas M. Wojcik has been named chief operating officer and Dava E. Ritchea chief financial officer, starting April 1. Ritchea has previously served as CFO at Sculptor Capital Management and Assured Investment Management, the company said. Wojcik and Ritchea will report to President and...
Sintx Technologies Shares Slump After Pricing $1.3 Million Stock Offering
Sintx Technologies Shares Slump After Pricing $1.3 Million Stock Offering
Mar 25, 2024
11:56 AM EDT, 03/25/2024 (MT Newswires) -- Sintx Technologies ( SINT ) shares slid about 47% in recent Monday trading after the company said it priced its public offering of 28.4 million shares at $0.047 per share for gross proceeds of about $1.3 million. The offering is expected to close Tuesday. Maxim Group is the placement agent. The company said...
Rhythm Pharmaceuticals Doses First Patients in Phase 1 Trial of Potential Obesity Therapy
Rhythm Pharmaceuticals Doses First Patients in Phase 1 Trial of Potential Obesity Therapy
Mar 25, 2024
11:48 AM EDT, 03/25/2024 (MT Newswires) -- Rhythm Pharmaceuticals ( RYTM ) said Monday that the first patients were dosed in the phase 1 trial of RM-718 to treat obesity. RM-718 is a weekly melanocortin-4 receptor-specific agonist that has demonstrated the potential to reduce body weight and hunger in preclinical studies, the company said. The three-part study will evaluate the...
--Digital World Acquisition Completes Merger with Trump Media & Technology Group
--Digital World Acquisition Completes Merger with Trump Media & Technology Group
Mar 25, 2024
11:53 AM EDT, 03/25/2024 (MT Newswires) -- Price: 41.42, Change: +4.48, Percent Change: +12.12 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved